The Bill & Melinda Gates Foundation has announced a historic $2.5 billion investment in women’s health, committing the funds through 2030 to accelerate research and innovation in five critical areas of care. The pledge comes as global funding for maternal and reproductive health faces deep cuts—particularly from the Trump administration’s rollback of foreign aid and domestic health programs.

The Gates Foundation’s initiative will target obstetric care, maternal health and nutrition, menstrual and gynecological health, contraceptive access, and the diagnosis and treatment of sexually transmitted infections (STIs). Dr. Anita Zaidi, president of the foundation’s Gender Equality Division, said these areas were chosen because they meet three key criteria: they represent significant global health burdens, they have long been neglected in research, and they are ripe for affordable, scalable innovations.

“Women’s health has been underfunded for too long,” Zaidi said in a recent interview. “We’re focusing on areas where there is a high unmet need and where scientific progress—especially through AI—can yield real, life-saving impact within the next five years.”

Zaidi, a pediatrician by training who spent years working in low-resource settings in Pakistan, recalled witnessing firsthand the human cost of delayed or inaccurate care. She cited delayed Caesarean sections as one example. “We don’t always have the tools to know when a woman needs surgery—and sometimes we guess wrong. That’s a global issue.”

New technologies, especially AI, could help physicians in low- and middle-income countries better diagnose when women need life-saving interventions, Zaidi explained. “One of the most transformative things we’ll see in the next five years is AI-driven tools for safe delivery decisions,” she said.

The foundation’s announcement lands at a time when the U.S. government is slashing support for global and domestic health programs, including maternal care and family planning. Zaidi said the Gates Foundation’s pledge is not a reaction to these cuts, but a long-planned investment intended to catalyze additional action.

“We hope this sparks greater attention and investment from other funders—whether it’s private philanthropy or the private sector,” Zaidi said. “This $2.5 billion is the largest commitment the foundation has ever made to a single R&D area. But even so, it’s a drop in the bucket compared to the need.”

According to a 2021 study, just 1% of all health care research and innovation is directed at female-specific conditions outside of cancer. Zaidi attributes this disparity to long-standing structural biases in medicine, where the male body has historically been treated as the default.

“We assume that what works for men works for women,” she said. But there are fundamental biological differences between men and  women that need different solutions.”

Zaidi emphasized that investing in women’s health pays dividends across families and communities. “Children cannot thrive where women aren’t thriving,” she said. “If we want to  decrease child mortality around the world,  you really need to focus on women’s health.”
 
The Gates Foundation hopes its announcement will mark not just a financial investment, but a turning point in global health equity.